| Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT‐2 trial MJ Li, B Chau, T Belin, T Carmody, MK Jha, EN Marino, M Trivedi, ... Addiction, 2024 | | 2024 |
| Ketamine vs electroconvulsive therapy for treatment-resistant depression: a secondary analysis of a randomized clinical trial MK Jha, ST Wilkinson, K Krishnan, KA Collins, G Sanacora, J Murrough, ... JAMA network open 7 (6), e2417786-e2417786, 2024 | | 2024 |
| Problematic substance use in depressed adolescents: Prevalence and clinical correlates EN Marino, MK Jha, A Minhajuddin, ER Ayvaci, S Levinson, R Pipes, ... Addictive Behaviors Reports 19, 100539, 2024 | 1 | 2024 |
| Association Between Immune Dysregulation and Response to Naltrexone-Bupropion Combination in Methamphetamine Use Disorder: Findings From the ADAPT-2 Study K Baig-Ward, M Jha, A Minhajuddin, CC Fatt, T Carmody, B Mason-Mah, ... Biological Psychiatry 95 (10), S72-S73, 2024 | | 2024 |
| Neurophysiological Applications for Estimating Suicide Risk Reduction in a TMS Clinic N Murphy, A Minhajuddin, R Toll, S Mathew, M Jha, M Trivedi Biological Psychiatry 95 (10), S72, 2024 | | 2024 |
| Resting-State Brain Functional Connectivity Predictors of Differential Improvement in Irritability With Sertraline Versus Placebo: Findings From the EMBARC Study M Jha, CC Fatt, A Minhajuddin, M Trivedi Biological Psychiatry 95 (10), S19, 2024 | | 2024 |
| Parent/Guardian-and Self-Report Versions of the Irritability Domain of the Concise Associated Symptom Tracking Scale: Evaluation of Psychometric Properties and Potential … MK Jha, A Minhajuddin, R Baronia, JC Blader, T Mayes, MA Petrosky, ... JAACAP Open, 2024 | | 2024 |
| Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial GI Papakostas, MH Trivedi, RC Shelton, DV Iosifescu, ME Thase, MK Jha, ... Molecular psychiatry, 1-9, 2024 | 1 | 2024 |
| Treatment of Adolescent Depression: Comparison of Psychiatric and Pediatric Settings at an Academic Medical Center Using the VitalSign6 Application ER Ayvaci, A Minhajuddin, JS Elmore, K Yagnik, MK Jha, GJ Emslie, ... Journal of Child and Adolescent Psychopharmacology 34 (2), 80-88, 2024 | 1 | 2024 |
| Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials SR Vreijling, CRC Fatt, LM Williams, AF Schatzberg, T Usherwood, ... The British Journal of Psychiatry 224 (3), 89-97, 2024 | 1 | 2024 |
| Data-driven subgrouping of youths with depression reveals that resilience is associated with higher physical functioning despite high symptom burden in the Texas Youth … A Minhajuddin, MK Jha, H Slater, TL Mayes, EA Storch, J Shotwell, ... Journal of affective disorders 348, 353-361, 2024 | 1 | 2024 |
| -Immune biomarkers in psychiatric illness: Findings from the biomarker subgroup of the NSAS Brain-Immune Interactions Workshop C Bartley, G Lombardo, MK Jha, B Chaumette, J Hagenberg, R Rey, ... Psychoneuroendocrinology 160, 106894, 2024 | | 2024 |
| -Association of Neuropsychiatric Symptoms with Inflammation: Review Findings from the Workshop on Brain Immune Interactions M Jha, L Sforzini, Y Milaneschi, O Godin, LM Hack, CM Pariante, ... Psychoneuroendocrinology 160, 106896, 2024 | | 2024 |
| Evaluation of the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Moderate‐to‐Severe Hospitalized COVID‐19 Patients: A Randomized, Open‐Label Parallel‐Group Study S Gautam, G Mawari, MK Daga, N Kumar, H Singh, S Garg, S Kumar, ... Canadian Journal of Infectious Diseases and Medical Microbiology 2024 (1 …, 2024 | | 2024 |
| Anti-suicidal effects of IV ketamine in a real-world setting B O'Brien, J Lee, S Kim, GS Nandra, P Pannu, A Tamman, D Amarneh, ... Psychiatry research 331, 115604, 2024 | 1 | 2024 |
| Combining Ketamine with Trauma-Focused Psychotherapy for Chronic PTSD-A Pilot Clinical Trial A Feder, O Brown, L Cahn, S Rutter, S Costi, J Overbey, A Delgado, ... NEUROPSYCHOPHARMACOLOGY 48, 77-77, 2023 | | 2023 |
| Multidimensional Assessment of Fatigue in Depressed Adults: Associations With Childhood Trauma and Potential Sex Differences M Jha, A Ghose, A Minhajuddin, M Trivedi NEUROPSYCHOPHARMACOLOGY 48, 228-229, 2023 | | 2023 |
| Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine? SJ Mathew, MK Jha, A Anand JAMA psychiatry 80 (12), 1187-1188, 2023 | 5 | 2023 |
| Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report MI Husain, JA Foster, BL Mason, S Chen, H Zhao, W Wang, S Rotzinger, ... CNS spectrums 28 (6), 739-746, 2023 | 1 | 2023 |
| Whose Interests Are Served By Promoting Antidepressants in Patients with Cardiovascular Disease? The Reply C Krittanawong, NS Maitra, YK Qadeer, Z Wang, S Fogg, EA Storch, ... AMERICAN JOURNAL OF MEDICINE 136 (11), 881-881, 2023 | | 2023 |
Madhukar TrivediUT Southwestern Medical School在 utsouthwestern.edu 的电子邮件经过验证
